Bio-Techne (TECH) Current Leases (2019 - 2026)
Bio-Techne (TECH) posted quarterly Current Leases of $14.2 million for Q1 2026, up 0.94% year-over-year from $14.0 million in Q1 2025, and up 3.44% quarter-over-quarter from $13.7 million in Q4 2025.
Bio-Techne (TECH) Current Leases (2019 - 2026) Analysis & Trends
Bio-Techne's Current Leases history runs 8 years deep, the most recent figure standing at $14.2 million for Q1 2026.
- In Q1 2026, Current Leases rose 0.94% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (up 0.94% YoY), while the FY2025 annual figure was $14.1 million, up 9.12% from the prior year.
- Current Leases for Q1 2026 stood at $14.2 million, up from $13.7 million in the prior quarter.
- The five-year high for Current Leases was $14.2 million in Q1 2026, with the low at $10.7 million in Q1 2023.
- The 5-year median for Current Leases is $12.9 million (2024), against an average of $12.7 million.
- The sharpest annual moves came in 2023 and 2024: Current Leases declined 9.62% in 2023, then gained 21.03% in 2024.
- Bio-Techne's Current Leases stood at $11.0 million in 2022, then gained by 15.46% to $12.7 million in 2023, then rose by 6.62% to $13.5 million in 2024, then climbed by 1.47% to $13.7 million in 2025, then gained by 3.44% to $14.2 million in 2026.
- Business Quant data shows TECH's Current Leases at $14.2 million in Q1 2026, $13.7 million in Q4 2025, and $13.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 14.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.18 Mn |
| Dec 31, 2025 | 13.71 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 14.10 Mn |
| Mar 31, 2025 | 14.05 Mn |
| Dec 31, 2024 | 13.51 Mn |
| Sep 30, 2024 | 13.49 Mn |
| Jun 30, 2024 | 12.92 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 12.67 Mn |
| Sep 30, 2023 | 12.20 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 12.12 Mn |
| Jun 30, 2022 | 11.93 Mn |
| Mar 31, 2022 | 11.86 Mn |
| Dec 31, 2021 | 11.81 Mn |
| Sep 30, 2021 | 12.00 Mn |
| Jun 30, 2021 | 11.60 Mn |